Panacea Biotec receives CDR-EG approval for debt restructuring proposal

29 Sep 2014 Evaluate

Panacea Biotec has received CDR-EG approval for debt restructuring proposal. The Corporate Debt Restructuring Empowered Group (CDR-EG) had in its meeting held on September 09, 2014, approved Panacea Biotec’s Corporate Debt Restructuring (CDR) proposal which was referred to CDR Cell on December 21, 2013 and admitted by CDR -EG on January 24, 2014 and the LOA dated September 24, 2014 had been issued by CDR EG in this regard.

The necessary steps for implementation of the proposal shall be taken in due course of time in coordination with the Lenders.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

429.45 -22.60 (-5.00%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.